We've found
2,839 High Blood Pressure (Hypertension)
clinical trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Prevention Trial to Achieve Cardiovascular Targets
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
An Extension Study for Patients Who Participated in the CAMN107X2201 Study
Status: Enrolling
Updated: 10/23/2012
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
An Extension Study for Patients Who Participated in the CAMN107X2201 Study
Status: Enrolling
Updated: 10/23/2012
Click here to add this to my saved trials
Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Pharmacokinetics of Sildenafil in Premature Infants
Status: Enrolling,
Phase
I
Updated: 7/14/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma
Status: Enrolling
Updated: 1/11/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Reproductive Clinical Trial
Epigenomic Dysregulation in Preeclampsia-Associated Chronic Hypertension
Status: Enrolling
Updated: 3/13/2013
Click here to add this to my saved trials
Hypertension Clinical Trial
Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension
Status: Enrolling,
Phase
II
Updated: 10/29/2012
Click here to add this to my saved trials
Pulmonary Hypertension Clinical Trial
Side Effects of Pulmonary Hypertension Medications
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Nephrology / Urology, Other Clinical Trial
Study to Assess the Effects of Intravenous Bendavia in Patients Undergoing Percutaneous Transluminal Angioplasty of the Renal Artery (PTRA)
Status: Enrolling,
Phase
I, II
Updated: 4/27/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery Clinical Trial
Novel Screening Strategies for Scleroderma PAH
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension Clinical Trial
Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function
Status: Enrolling,
Phase
II
Updated: 9/21/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Resveratrol and Cardiovascular Health in the Elderly
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Nephrology / Urology Clinical Trial
Mechanisms of Intradialytic Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension Clinical Trial
Controlling and Lowering Blood Pressure With The MOBIUSHD™
Status: Enrolling,
Phase
I
Updated: 11/28/2016
Click here to add this to my saved trials
Hypertension Clinical Trial
Controlling and Lowering Blood Pressure With The MOBIUSHD™
Status: Enrolling,
Phase
I
Updated: 11/28/2016
Click here to add this to my saved trials
Hypertension Clinical Trial
Controlling and Lowering Blood Pressure With The MOBIUSHD™
Status: Enrolling,
Phase
I
Updated: 11/28/2016
Click here to add this to my saved trials
Hypertension Clinical Trial
Study 3: Minocycline Decreases Microglia Activation
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension Clinical Trial
Diuretic Comparison Project
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension Clinical Trial
Diuretic Comparison Project
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension Clinical Trial
Diuretic Comparison Project
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension Clinical Trial
Diuretic Comparison Project
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Nephrology / Urology Clinical Trial
Improving Chronic Disease Management With Pieces
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Nephrology / Urology Clinical Trial
Improving Chronic Disease Management With Pieces
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
2,839 High Blood Pressure (Hypertension)
clinical trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/13/2016
Prevention Trial to Achieve Cardiovascular Targets
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Updated: 10/23/2012
An Extension Study for Patients Who Participated in the CAMN107X2201 Study
Status: Enrolling
Updated: 10/23/2012
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Updated: 10/23/2012
An Extension Study for Patients Who Participated in the CAMN107X2201 Study
Status: Enrolling
Updated: 10/23/2012
Click here to add this to my saved trials
Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Updated: 7/14/2016
Pharmacokinetics of Sildenafil in Premature Infants
Status: Enrolling,
Phase
I
Updated: 7/14/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 1/11/2013
Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma
Status: Enrolling
Updated: 1/11/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Reproductive Clinical Trial
Updated: 3/13/2013
Epigenomic Dysregulation in Preeclampsia-Associated Chronic Hypertension
Status: Enrolling
Updated: 3/13/2013
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 10/29/2012
Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension
Status: Enrolling,
Phase
II
Updated: 10/29/2012
Click here to add this to my saved trials
Pulmonary Hypertension Clinical Trial
Updated: 12/31/1969
Side Effects of Pulmonary Hypertension Medications
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Nephrology / Urology, Other Clinical Trial
Updated: 4/27/2015
Study to Assess the Effects of Intravenous Bendavia in Patients Undergoing Percutaneous Transluminal Angioplasty of the Renal Artery (PTRA)
Status: Enrolling,
Phase
I, II
Updated: 4/27/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery Clinical Trial
Updated: 12/31/1969
Novel Screening Strategies for Scleroderma PAH
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 9/21/2015
Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function
Status: Enrolling,
Phase
II
Updated: 9/21/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Updated: 4/4/2016
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Updated: 4/4/2016
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Updated: 4/4/2016
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Updated: 12/31/1969
Resveratrol and Cardiovascular Health in the Elderly
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 12/31/1969
Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Mechanisms of Intradialytic Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Updated: 12/31/1969
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Updated: 12/31/1969
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Updated: 12/31/1969
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 11/28/2016
Controlling and Lowering Blood Pressure With The MOBIUSHD™
Status: Enrolling,
Phase
I
Updated: 11/28/2016
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 11/28/2016
Controlling and Lowering Blood Pressure With The MOBIUSHD™
Status: Enrolling,
Phase
I
Updated: 11/28/2016
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 11/28/2016
Controlling and Lowering Blood Pressure With The MOBIUSHD™
Status: Enrolling,
Phase
I
Updated: 11/28/2016
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 12/31/1969
Study 3: Minocycline Decreases Microglia Activation
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 12/31/1969
Diuretic Comparison Project
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 12/31/1969
Diuretic Comparison Project
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 12/31/1969
Diuretic Comparison Project
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 12/31/1969
Diuretic Comparison Project
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 12/31/1969
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 12/31/1969
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 12/31/1969
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 12/31/1969
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Improving Chronic Disease Management With Pieces
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Improving Chronic Disease Management With Pieces
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Updated: 12/31/1969
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Updated: 12/31/1969
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Updated: 12/31/1969
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Updated: 12/31/1969
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Updated: 12/31/1969
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials